首页|微小RNA-15a表达与妊娠期糖尿病患者胎儿心脏畸形的关系分析

微小RNA-15a表达与妊娠期糖尿病患者胎儿心脏畸形的关系分析

扫码查看
目的 探讨微小RNA-15a(miR-15a)表达与妊娠期糖尿病(GDM)患者胎儿心脏畸形的关系.方法 选取891例GDM患者作为疾病组,同时选取健康孕妇891例作为健康组,检测并比较2组母体血清miR-15a表达.根据疾病组是否发生胎儿心脏畸形将其分为畸形组和非畸形组,比较2组血清miR-15a表达及一般资料.另根据确诊孕周将疾病组患者分为A组和B组,根据空腹血糖升高程度将血糖控制不良患者分为C组和D组.采用多因素Logistic回归分析法分析GDM患者胎儿心脏畸形影响因素.绘制受试者工作特征(ROC)曲线分析血清miR-15a表达对GDM患者胎儿心脏畸形的预测价值.结果 疾病组血清miR-15a表达高于健康组,差异有统计学意义(P<0.001).GDM患者中胎儿心脏畸形发生率为2.87%(24/835).畸形组血清miR-15a表达、年龄、孕前体质量指数和不良孕产史、血糖控制不良占比高于非畸形组,妊娠早期规律服用叶酸占比低于非畸形组,差异有统计学意义(P<0.05).A组、B组的血清miR-15a表达、胎儿心脏畸形发生率比较,差异无统计学意义(P>0.05).D组血清miR-15a表达、胎儿心脏畸形发生率高于C组,差异有统计学意义(P<0.05).血清miR-15a表达(OR=16.651,95%CI:6.252~44.344)、年龄(OR=1.078,95%CI:1.006~1.156)、血糖控制不佳(OR=3.404,95%CI:1.852~5.137)是GDM患者胎儿心脏畸形的影响因素(P<0.05).血清miR-15a表达预测GDM患者胎儿心脏畸形的最佳临界值、灵敏度、特异度、曲线下面积分别为2.34、87.50%、73.24%、0.827(95%CI:0.799~0.852).结论 在GDM患者中,血清miR-15a表达异常升高,其是预测GDM患者胎儿心脏畸形的有效指标.
Analysis of the relationship between microRNA-15a expression and fetal heart malformation in patients with gestational diabetes mellitus
Objective To investigate the relationship between the expression of microRNA-15a(miR-15a)and fetal heart malformation in patients with gestational diabetes mellitus(GDM).Meth-ods A total of 891 patients with GDM were selected as disease group and 891 healthy pregnant women were selected as healthy group,the expression of serum miR-15a was detected and compared between the two groups.The disease group was divided into malformed group and non-malformed group according to whether fetal heart malformation occurred,serum miR-15a expression and general data of the two groups were compared.The patients in the disease group were divided into group A and group B according to the confirmed gestational age,and the patients with poor blood glucose con-trol were divided into group C and group D according to the degree of fasting blood glucose elevation.Multivariate Logistic regression analysis was used to analyze the influencing factors of fetal heart malforma-tion in GDM patients.Receiver operating characteristic(ROC)curve was drawn to analyze the predictive value of serum miR-15a expression in fetal heart malformation in GDM patients.Results Serum miR-15a expression in the disease group was significantly higher than that in the healthy group(P<0.001).The incidence of fetal heart malformation in GDM patients was 2.87%(24/835).The proportion of serum miR-15a expression,age,pre-pregnancy body mass index,adverse pregnancy history and poor blood glucose control in the malformed group was significantly higher than that in the non-malformed group,and the proportion of regular folic acid administration in early pregnancy was significantly lower than that in the non-malformed group(P<0.05).There was no significant difference in serum miR-15a expression and incidence of fetal heart malformation between the group A and group B(P>0.05).The expression of serum miR-15a and the incidence of fetal heart mal-formation in the group D were significantly higher than those in the group C(P<0.05).Serum miR-15a expression(OR=16.651,95%CI,6.252 to 44.344),age(OR=1.078,95%CI,1.006 to 1.156),poor blood glucose control(OR=3.404,95%CI,1.852 to 5.137)were the in-fluencing factors of fetal heart malformation in GDM patients(P<0.05).The optimal critical val-ue,sensitivity,specificity and area under the curve for predicting fetal heart malformation in GDM patients were 2.34,87.50%,73.24%and 0.827(95%CI,0.799 to 0.852),respectively.Conclusion In GDM patients,serum miR-15a expression is abnormally elevated,which is an ef-fective indicator for predicting fetal heart malformation in GDM patients.

gestational diabetesmicroRNA-15afetal heart malformationglycemic control

王彦、周淑、于萍、余建、张瑞琪

展开 >

四川大学华西第二医院中国出生缺陷监测中心,四川成都,610000

四川锦欣妇女儿童医院产科,四川成都,610000

妊娠期糖尿病 微小RNA-15a 胎儿心脏畸形 血糖控制

四川省科技计划

2018SZ0269

2024

实用临床医药杂志
扬州大学,中国高校科技期刊研究会

实用临床医药杂志

CSTPCD
影响因子:1.543
ISSN:1672-2353
年,卷(期):2024.28(4)
  • 21